Australian Clinical Labs Ltd
ASX:ACL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.16
3.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Australian Clinical Labs Ltd
Wall Street
Price Targets
ACL Price Targets Summary
Australian Clinical Labs Ltd
According to Wall Street analysts, the average 1-year price target for
ACL
is 3.59 AUD
with a low forecast of 2.98 AUD and a high forecast of 4.2 AUD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACL's stock price target?
Price Target
3.59
AUD
According to Wall Street analysts, the average 1-year price target for
ACL
is 3.59 AUD
with a low forecast of 2.98 AUD and a high forecast of 4.2 AUD.
What is Australian Clinical Labs Ltd's Revenue forecast?
Projected CAGR
5%
For the last 6 years the
compound annual growth rate for
Australian Clinical Labs Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
5%.
What is Australian Clinical Labs Ltd's Operating Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Australian Clinical Labs Ltd's operating income for the next 3 years is
13%.
What is Australian Clinical Labs Ltd's Net Income forecast?
Projected CAGR
28%
The
compound annual growth rate
of Australian Clinical Labs Ltd's net income for the next 3 years is
28%.
You don't have any saved screeners yet
